In the present study, we first investigated the ability and mechanism of PM to reduce the degree of AngII‐induced cardiomyocyte hypertrophy in vitro and TAC‐induced cardiac hypertrophy in vivo. The gene discussed is AGT; the disease is persistent truncus arteriosus.